RESEARCH & INNOVATION SHOWCASE Dr Trish Murray Senior Lecturer in Stem Cell/Developmental Biology, ITM Senior scientist in the UK Regenerative Medicine.

Slides:

Advertisements

Similar presentations

The way forward: Development of joint S&T Human Capital Dr. Agrita Kiopa, Ministry of Education and Science

Advertisements

Personalized Medicine in California Kathryn Lowell, Deputy Secretary for Life Sciences and Health Systems February, 2009.

Biotechnology and Medicine Prof. S.K.Panda Department of Pathology All India Institute of Medical Sciences.

Integrative Organs Systems Scientists and Drug Discovery: The Link Between Big Pharma and Academia Glenn A. Reinhart, Ph.D. Senior Group Leader Integrative.

1 Confidential Science of Stem Cells and Potential Applications Andrea Hunt February 22, 2008.

Stem Cell Dream: From Reality to Dreams. EuroStemCell is a unique partnership of European scientists, clinicians, ethicists, social scientists and science.

1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.

Nanotechnology in Drug Discovery- Development and Delivery

Therapeutic Peptides for Cardiovascular Disease and Cancer Cam Patterson, MD, MBA, FACC, FAHA Ernest and Hazel Craige Distinguished Professor of Cardiovascular.

Stem Cell Biology Basics Nozad H. Stem cell workshop Stem cell Research center Tabriz medical university In The Name of God.

Improving Animal and Human Health by Accelerating Veterinary Centered Entrepreneurship.

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.

Promoting improvement in the quality of health and social care Local action planning in mental health: Using NCISH recommendations to help improve care.

Dr. Manu O. Platt March 10, 2009 Leveraging FACES to Aid Starting in Academia.

Dr. Ziad W Jaradat Cancer Stem Cells. Recently biologically distinct and relatively rare populations of tumor-initiating cells have been identified in.

Stem Cells Stem cells are immature cells that have not turned into specific cells yet; they haven’t become blood or skin, or anything else Stem cells.

BY Nisvil Smith.  Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material to diagnose and determine the severity.

Biomedical Engineering

1.Disease: heart, kidney, liver 2.Trauma 3.Environment: x-rays, 2 nd hand smoke 4. Aging 5.Congenital Defects: cleft palate, heart.

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 7 Over-the-Counter Drugs and Herbal and Dietary.

The Science of Embryonic Stem Cells by Arun Bharatula.

RMIT University© 1 Health Innovations Research Institute (HIRi) Translating fundamental science into.

Adaptive Licensing UK. Content What is adaptive licensing? Draft criteria for pilot candidate selection EMA Road Map 2015 and work programme 2012 UK perspective.

Types of Cloning Reproductive Cloning – making copies of a whole animal/human – useful to propagate transgenic /genetically modified organisms Therapeutic.

Biotechnology Industry Organization (BIO) Risk Management Public Workshop Day 1 - April 9, 2003 Risk Assessment in Drug and Biological Development Joanna.

European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.

European Patients’ Academy on Therapeutic Innovation Special Populations.

Mechanisms to support collaboration between universities and industry Vivienne Stern Director UK Higher Education International Unit.

Regenerative Medicine Regenerative medicine~ Goal: to grow replacement tissue or organs for patients who have sustained an injury or have a disease that.

Sun Damage and Sun Benefits Strengthening the European personal care, body hygiene and beauty products industrial sector Dr Jack Ferguson 17 May 2016 Skinnovation.

Regenerative Medicine Regenerative medicine~ Goal: to grow replacement tissue or organs for patients who have sustained an injury or have a disease that.

Bringing Genomics Home Your DNA: A Blueprint for Better Health Genome British Columbia November 18, 2015 / West Vancouver, BC.

The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.

Introductions Dr Emma Bowers Training Coordinator Talk about: NTC Blended learning Master’s Programme Joe Spoor 1 st year STP trainee Lauren Slater 1 st.

IN THE NAME OF GOD. What are Stem Cells? Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types.

By: Aaron Mills. How stem cells are retrieved A typical day-5 human embryo consists of cells Only about of these cells are usable HESCs.

 (1) recombinant DNA technology or DNA cloning,  (2) reproductive cloning  (3) therapeutic cloning.

Technological excellence

Augustas Pivoriūnas, M. D. , Ph. D

Brain Tumour Bank at Institute of Neurology

Stem Cells in Wound Healing: The Future of Regenerative Medicine

Developing chemically modified, non-anticoagulant heparin derivatives as galectin-3-targeted novel anti-cancer/anti-metastasis drugs Professor Lu-Gang.

EU funding opportunities

Advancing Stem Cell Biology toward Stem Cell Therapeutics

Regenerative Medicine Market Is Expected To Reach $ Million By 2025 | CAGR 33.05% - Progressive Markets - Size, Trend, Share, Opportunity Analysis.

Extracellular vesicles for molecular delivery system

RESEARCH & INNOVATION SHOWCASE Dr Jill Madine

Plant and Animal Biotechnology

M.H. Li, R. Xiao, J.B. Li, Q. Zhu Osteoarthritis and Cartilage

Advancing the Treatment of IBD With Biologics

Treating CD30-Expressing Cutaneous T-Cell Lymphoma

DNA CLONING IN CANCER TREATMENT : GENE INFUSION (CAR-T Therapy)

Genetic Engineering Research

Renal Association UK Renal Registry.

Pledge for Parity -A Showcase Event

Nat. Rev. Nephrol. doi: /nrneph

Technological excellence

LEARN ABOUT OUR PURPOSE & COMITTMENT TO IMPROVING PATIENT QUALITY OF LIFE Skye Biologics, a U.S.-based leader in biotechnology, was founded in 2006 to.

The Stem Cell Niche in Regenerative Medicine

VES4US Extracellular vesicles from a natural source for tailor-made nanomaterials.

Dr. Hsiu-Jung Lo, Investigator

Renal Association UK Renal Registry.

Plant and Animal Biotechnology

Web-based Binational Student Presentations

Ondřej Zítka Datum konání:

Renal Association UK Renal Registry.

Stem Cell Research.

Renal Association UK Renal Registry.

Presentation transcript:

RESEARCH & INNOVATION SHOWCASE Dr Trish Murray Senior Lecturer in Stem Cell/Developmental Biology, ITM Senior scientist in the UK Regenerative Medicine Platform Safety and Efficacy Hub, focussing on imaging technologies Key interests: - Potential of regenerative medicine therapies (RMTs) to treat kidney disease - Development of imaging strategies to assess efficacy, safety and mechanisms of action of RMTs

RESEARCH & INNOVATION SHOWCASE We use a range of imaging technologies to monitor efficacy and safety of cell therapies and understand their mechanisms of action 3 weeks 4 d 3 h Safety Efficacy Biluminescence imaging shows some cell types form tumours Photoacoustic imaging shows effects of RMTs on renal function Mechanisms Therapeutic effects mediated by endocrine factors

RESEARCH & INNOVATION SHOWCASE Our results suggest that therapeutic effects are likely to be mediated by ‘extracellular vesicles’ (EVs) derived from the cells These EVs are likely to be more effective and safer than cell based RMTs What is needed from an industry partner? QA, scale-up